Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

279 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
COMMD3 loss drives invasive breast cancer growth by modulating copper homeostasis.
Hancock JL, Kalimutho M, Straube J, Lim M, Gresshoff I, Saunus JM, Lee JS, Lakhani SR, Simpson KJ, Bush AI, Anderson RL, Khanna KK. Hancock JL, et al. Among authors: khanna kk. J Exp Clin Cancer Res. 2023 Apr 18;42(1):90. doi: 10.1186/s13046-023-02663-8. J Exp Clin Cancer Res. 2023. PMID: 37072858 Free PMC article.
Mutation analysis of five candidate genes in familial breast cancer.
Marsh A, Healey S, Lewis A, Spurdle AB, Kedda MA, Khanna KK; kConFab; Mann GJ, Pupo GM, Lakhani SR, Chenevix-Trench G. Marsh A, et al. Among authors: khanna kk. Breast Cancer Res Treat. 2007 Nov;105(3):377-89. doi: 10.1007/s10549-006-9461-z. Epub 2006 Dec 23. Breast Cancer Res Treat. 2007. PMID: 17187232
Heregulin-HER3-HER2 signaling promotes matrix metalloproteinase-dependent blood-brain-barrier transendothelial migration of human breast cancer cell lines.
Momeny M, Saunus JM, Marturana F, McCart Reed AE, Black D, Sala G, Iacobelli S, Holland JD, Yu D, Da Silva L, Simpson PT, Khanna KK, Chenevix-Trench G, Lakhani SR. Momeny M, et al. Among authors: khanna kk. Oncotarget. 2015 Feb 28;6(6):3932-46. doi: 10.18632/oncotarget.2846. Oncotarget. 2015. PMID: 25668816 Free PMC article.
Using the MCF10A/MCF10CA1a Breast Cancer Progression Cell Line Model to Investigate the Effect of Active, Mutant Forms of EGFR in Breast Cancer Development and Treatment Using Gefitinib.
Bessette DC, Tilch E, Seidens T, Quinn MC, Wiegmans AP, Shi W, Cocciardi S, McCart-Reed A, Saunus JM, Simpson PT, Grimmond SM, Lakhani SR, Khanna KK, Waddell N, Al-Ejeh F, Chenevix-Trench G. Bessette DC, et al. Among authors: khanna kk. PLoS One. 2015 May 13;10(5):e0125232. doi: 10.1371/journal.pone.0125232. eCollection 2015. PLoS One. 2015. PMID: 25969993 Free PMC article.
Adenosine 2B Receptor Expression on Cancer Cells Promotes Metastasis.
Mittal D, Sinha D, Barkauskas D, Young A, Kalimutho M, Stannard K, Caramia F, Haibe-Kains B, Stagg J, Khanna KK, Loi S, Smyth MJ. Mittal D, et al. Among authors: khanna kk. Cancer Res. 2016 Aug 1;76(15):4372-82. doi: 10.1158/0008-5472.CAN-16-0544. Epub 2016 May 24. Cancer Res. 2016. PMID: 27221704
Multidimensional phenotyping of breast cancer cell lines to guide preclinical research.
Saunus JM, Smart CE, Kutasovic JR, Johnston RL, Kalita-de Croft P, Miranda M, Rozali EN, Vargas AC, Reid LE, Lorsy E, Cocciardi S, Seidens T, McCart Reed AE, Dalley AJ, Wockner LF, Johnson J, Sarkar D, Askarian-Amiri ME, Simpson PT, Khanna KK, Chenevix-Trench G, Al-Ejeh F, Lakhani SR. Saunus JM, et al. Among authors: khanna kk. Breast Cancer Res Treat. 2018 Jan;167(1):289-301. doi: 10.1007/s10549-017-4496-x. Epub 2017 Sep 9. Breast Cancer Res Treat. 2018. PMID: 28889351
Characterization of a novel breast cancer cell line derived from a metastatic bone lesion of a breast cancer patient.
Johnson J, Bessette DC, Saunus JM, Smart CE, Song S, Johnston RL, Cocciardi S, Rozali EN, Johnstone CN, Vargas AC, Kazakoff SH, BioBank VC, Khanna KK, Lakhani SR, Chenevix-Trench G, Simpson PT, Nones K, Waddell N, Al-Ejeh F. Johnson J, et al. Among authors: khanna kk. Breast Cancer Res Treat. 2018 Jul;170(1):179-188. doi: 10.1007/s10549-018-4719-9. Epub 2018 Feb 21. Breast Cancer Res Treat. 2018. PMID: 29468485
CEP55 is a determinant of cell fate during perturbed mitosis in breast cancer.
Kalimutho M, Sinha D, Jeffery J, Nones K, Srihari S, Fernando WC, Duijf PH, Vennin C, Raninga P, Nanayakkara D, Mittal D, Saunus JM, Lakhani SR, López JA, Spring KJ, Timpson P, Gabrielli B, Waddell N, Khanna KK. Kalimutho M, et al. Among authors: khanna kk. EMBO Mol Med. 2018 Sep;10(9):e8566. doi: 10.15252/emmm.201708566. EMBO Mol Med. 2018. PMID: 30108112 Free PMC article.
279 results